Much like 2025, 2026 is shaping up to be a year full of turmoil and uncertainty for public health and the biomedical sciences. But while we’re still flying blind in many respects, we’ve learned some lessons along the way that we can put to use as we continue to navigate the storm. At the end of last year, we had the pleasure of giving our first workshop in a series on health communication for a local county health department. This was an exciting opportunity for us to engage

Every now and then, a major news publication will post a story with a headline like, “ HIV can be completely eliminated in laboratory...

Image by Jan from Pixabay This post was created in collaboration with M.E. Sidall . We often blame social media for the spread of...

Image adapted from ContuEd.com licensed under CC BY-SA 4.0 A couple of weeks ago, we attended the Society for Health Communication’s...

This is part two of our Pride month blog series, in which we   address the current social, legal, and medical landscape affecting the...

John H. McCool is Chief Scientific Editor at Precision Scientific Editing, LLC . He has edited over 1,500 scientific manuscripts for top...

Camille Ledoux, PhD As the chaos unfolding at the federal level continues to threaten the future of science and public health in the...

We’ve all heard the cliché that laughter is the best medicine. Of course, in public health we don’t take that literally, because we...

With the Trump administration's communications embargo on public health agencies  and the recent purge of CDC datasets, access to...

These days, it often feels like there is a seismic shift taking place in the biomedical sciences. With the incoming administration’s...

M&D is collaborating with Rachel Wedeward of Miss Research  to develop educational webinars to help public health professionals achieve...

It’s officially conference season in North America, and we recently returned from presenting at the American Medical Writers Association...

Now that the world is officially in the midst of another public health emergency, this time prompted by an epidemic of clade 1b mpox  in...

As we expand the reach and scope of our blog, M&D co-founder S. Patrick Murphy will now be regularly contributing on issues related to...

Paxlovid, the brand name for a combination therapy consisting of ritonavir and nirmatrelvir, is an oral antiviral medication available...

There’s been a lot of discussion in the media recently about the possibility of an avian flu outbreak in humans. This is a breakdown of...

Today the internet is essential to the way we connect, communicate, and collaborate, so it is no surprise that academic publishers are...